Advinus and Corning Sign Agreement to Bring Corning® Epic® Technology to India
02 Dicembre 2010 - 10:28AM
Business Wire
Advinus Therapeutics, the research-based pharmaceutical company
promoted by the TATA Group, and Corning Incorporated (NYSE: GLW)
today announced a collaboration to bring Corning® Epic® label-free
detection technology to India.
The collaboration between Advinus and Corning enables Advinus to
leverage the Corning Epic technology to enhance its own drug
discovery capabilities and to provide assay development and
screening services to companies both in India and abroad. “This
collaboration is in line with Corning’s strategy of bringing
innovative technology to India through collaborations with leading
Indian companies,” said Rustom Desai, President, Corning India.
Corning Epic technology combines biochemical detection and
cellular analysis on a single label-free platform to enable a
better understanding of biological activity for a wide range of
research applications. Corning’s technology helps accurately
identify targets, pathways, and interactions, providing more
biologically relevant data to the drug discovery process.
Commenting on the collaboration, Dr. Kasim Mookhtiar, the CSO of
Advinus, said, “This collaboration on Corning’s Epic technology
emphasizes Advinus’ commitment to set up unique Pharma R & D
services in India and to explore new and cutting-edge technologies
to enhance our drug discovery capabilities. We are excited about
the opportunities this will open for our customers and for our
relationship with Corning in the area of enhanced drug
discovery.”
"This collaboration highlights the growing adoption of
label-free technology and the biological insights it enables in
drug discovery research," said Ron Verkleeren, director, Advanced
Life Sciences. "We believe this is an important step forward in
making our Epic technology more accessible to life science
researchers worldwide."
About Corning Incorporated
(www.corning.com)
Corning Incorporated (www.corning.com) is the world leader in
specialty glass and ceramics. Drawing on more than 150 years of
materials science and process engineering knowledge, Corning
creates and makes keystone components that enable high-technology
systems for consumer electronics, mobile emissions control,
telecommunications and life sciences. Our products include glass
substrates for LCD televisions, computer monitors and laptops;
ceramic substrates and filters for mobile emission control systems;
optical fiber, cable, hardware & equipment for
telecommunications networks; optical biosensors for drug discovery;
and other advanced optics and specialty glass solutions for a
number of industries including semiconductor, aerospace, defense,
astronomy and metrology.
About Advinus Therapeutics
(www.advinus.com)
Advinus Therapeutics is a research-based Pharmaceutical Company
founded by leading global pharmaceutical executives and promoted by
the TATA Group. The company is the first of its kind in India to
offer end-to-end development services to the global Pharma, Agro
and Biotech industries and at the same time creating long-term
value through internal and collaborative innovative Drug Discovery.
Advinus Drug Discovery, located in a state of the art facility in
Pune (near Mumbai), is developing its own drug candidates with the
objective of out-licensing them at preclinical or clinical stages.
The therapeutic areas of focus of these programs are in Metabolic
Diseases, Inflammatory Diseases and neglected diseases such as
Leishmaniasis. Advinus’ Pharmaceutical development operation is
based out of Bangalore and is set on a 9-acre campus with 240,000
sq. ft of modern facilities. This center progresses our discovery
compounds from Pune through pre-clinical development by performing
all IND track studies and also by managing the early clinical
development of these compounds. The Bangalore center additionally
offers its capabilities of end-to-end pre-clinical to early
clinical development as services for pharmaceutical product
development. The services areas include Process Development,
Drug Metabolism and Pharmacokinetics, Clinical Pharmacology, Safety
Assessment and Analytical R&D. The Bangalore center is also one
of the most accredited R&D centers of India with certification
from AAALAC International and from the German, Dutch and Indian
authorities for GLP compliance. In its management and senior
leadership the team, the Company has over 150 years of drug
discovery and drug development experience in U.S. large
Pharmaceutical companies, with specific experience of handling
dozens of IND and NDA filings.
Grafico Azioni Corning (NYSE:GLW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Corning (NYSE:GLW)
Storico
Da Lug 2023 a Lug 2024